Innovating Works

OSIVAX

Desconocido
OSIRIX: Revolutionary vaccines to prevent pandemic and seasonal outbreaks of respiratory viral infections T... OSIVAX SAS tramitó un H2020: H2020-EIC-SMEInst-2018-2020 While an ongoing pandemic outbreak of coronavirus (COVID-19) is having enormous impact on global societies, a quest for effective vaccinatio...
2020-07-16 - 2022-09-30 | Financiado
OptiMalVax: Optimizing a deployable high efficacy malaria vaccine OSIVAX SAS participó en un H2020: H2020-SC1-2016-2017 A highly effective malaria vaccine against Plasmodium falciparum should help prevent half a million deaths from malaria each year. New vacc...
2016-12-09 - 2022-12-31 | Financiado
MultiViVax: Development of Effective Vaccines against Multiple Lifecycle Stages of Plasmodium vivax malaria OSIVAX SAS participó en un H2020: H2020-SC1-2016-2017 Plasmodium vivax is the most widespread malaria and constitutes a significant proportion of human malaria cases. P. vivax accounts for 100-4...
2016-12-09 - 2022-12-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.